Nitin Sood

Chief Executive Officer

An accomplished executive with a record of success leading businesses in the life science industry, Nitin joined Boreal in June 2011 as Chief Executive Officer.

Previously, Nitin served as General Manager of the Automation and Electrophoresis business units at Agilent Technologies where he led a global organization of R&D, marketing, sales and manufacturing supporting a portfolio of successful products like the Lab-on-chip Bioanalyzer, the Bravo Automated Liquid Handler and the Biocel Integrated system. Under Nitin’s leadership, the businesses demonstrated substantial growth by launching new products for life science applications in genomics, drug discovery and protein analysis. Prior to Agilent, Nitin led the R&D efforts for Applied Biosystems’ informatics business where he lead a team of engineers developing products targeted towards pharmaceutical QA/QC, forensics and chemical markets. Nitin holds master’s degrees in both computer science and molecular biology.

He can be reached at nsood@borealgenomics.com

 

Andre Marziali, PhD 

Founder, Chief Scientific Officer

A leading innovator, educator, and entrepreneur with over 18 years’ experience in developing tools for life science research and technologies for nucleic acid analysis, Andre founded Boreal Genomics with colleagues from the University of British Columbia in 2007.

Andre received his B.A.Sc. in Engineering Physics from UBC in 1989, and his Ph.D. in Physics from Stanford University in 1994. He subsequently worked for several years with Prof. Ron Davis, in the Stanford DNA Sequencing Technology Center, developing instruments for DNA sequencing and sample purification. He returned to Canada in 1998, as an Assistant Professor at University of British Columbia in the Department of Physics and Astronomy, where he founded the Applied Biophysics Laboratory and the Genome BC Technology Development Platform. In 2005 he was appointed Director of the Engineering Physics program at UBC.

In 2004, Andre co-invented the concept of using synchronous mobility perturbations to create divergent velocity fields for selective focusing of nucleic acids, the technology which forms the basis for Boreal’s platforms. He has been awarded the 2004 BC Innovation Council Young Innovator award, the 2007 Association for Lab Automation Innovation Award, and the 2011 Life Science BC Award for Innovation and Achievement.

Dara Grantham Wright, MBA

Chief Commercial Officer

An experienced business leader, Dara joined Boreal in October 2013 as Chief Commercial Officer bringing expertise in molecular oncology, pathology and clinical genetics.

Dara recently served as Global VP of Strategic Marketing, Clinical Genetics, at Affymetrix where she led clinical genetics, molecular diagnostics and clinical partner programs including responsibility for product strategy development, program execution, reimbursement and regulatory strategy. Prior to Affymetrix, Dara spent over 10 years in marketing and strategic marketing with BD Biosciences. Dara holds an M.B.A. from San Diego State University and B.A. cum laude from Willamette University.